Sort
8,912 grants matching “sars cov 2”
Impact of SARS CoV2 on Human Herpesvirus Co-Infections
$234,000Rebecca L Skalsky · Oregon Health & Science University · R21 · FY2025 · HL
Structure-Function Analysis of Human and Bat Coronavirus Spike Proteins
$234,000Krishna M.g. Mallela · University Of Colorado Denver · R21 · FY2024 · AI
Modifying Remdesivir Prodrug Design to Enhance the Active Metabolite Accumulation in the Lung (Resubmission)
$234,000Haojie Zhu · University Of Michigan At Ann Arbor · R21 · FY2022 · AI
Optogenetic stimulation of TMEM16F to control phospholipid flip-flop
$233,827Huanghe Yang · Duke University · R21 · FY2023 · GM
Targeting SARS-CoV-2 RNA Pseudoknots Using Triplex-Forming Peptide Nucleic Acids
$233,790Eriks Rozners · State University Of Ny,Binghamton · R21 · FY2023 · AI
Novel humanized mouse model of mucosal immunity
$233,445Anna Karolina Palucka · Jackson Laboratory · R21 · FY2024 · OD
Triple humanized ACE2-TMPRSS-FcGRT mouse models for COVID research in the C57BU6 and BALBIc backgrounds.
$233,363Kurt Jarnagin · Synbal, Inc. · R44 · FY2021 · AI
Host genetic resistance to COVID-19
$233,330Mary N. Carrington · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
RAPID: Coupled Contagion, Behavior-Change, and the Dynamics of Pro- and Anti-Social Behavior During the COVID-19 Pandemic
$233,283James H Jones · Stanford University · · FY2020 · SBE
Vaccine-Induced Mucosal T-Cell Immunity to Respiratory Viruses in Dirty Mice
$233,250Marulasiddappa Suresh · University Of Wisconsin-Madison · R21 · FY2023 · AI
Modeling the contribution of coronavirus cellular tropism to viral pathogenesis
$233,250Beverly H Koller · Univ Of North Carolina Chapel Hill · R21 · FY2023 · AI
SARS-CoV-2 N interactions with RNA and host cell cyclophilin-A
$233,250Elan Z Eisenmesser · University Of Colorado Denver · R21 · FY2023 · AI
COVID-19 comorbidity studies in Syrian hamster models
$233,250Yoshihiro Kawaoka · University Of Wisconsin-Madison · R21 · FY2022 · AI
mRNA encoding of immune receptor-targeting antibodies for the augmentation of vaccine-elicited cellular immunity.
$233,250Ross M Kedl · University Of Colorado Denver · R21 · FY2022 · AI
Identifying placental tissue tropism and cellular mechanisms of Ebola Virus transmission from mother to fetus in pregnancy
$233,250Wendy Jean Maury · University Of Iowa · UH2 · FY2024 · AI
A Novel Cell-based System for the Search of SARS-CoV-2 ORF3a Inhibitors against COVID-19
$233,250Richard Yuqi Zhao · University Of Maryland Baltimore · R21 · FY2024 · AI
Compressed sequential infection regimen to model immune responses to systemic and mucosal vaccination
$233,250Megan T Baldridge · Washington University · R21 · FY2024 · AI
Chitin and chitinases in SARS-CoV-2 infection
$233,250Steven Van Dyken · Washington University · R21 · FY2024 · AI
Concentration and single virion analysis of the virome
$233,250Dirk P Dittmer · Univ Of North Carolina Chapel Hill · U01 · FY2025 · DE
Concentration and single virion analysis of the virome
$233,250Dirk P Dittmer · Univ Of North Carolina Chapel Hill · U01 · FY2024 · DE
DiagnosDisk - a highly sensitive point-of-care test for detecting SARS-CoV-2 antigen in saliva
$233,250James Lai · University Of Washington · R21 · FY2021 · AI
SELF-MASKED ALDEHYDES AS INHIBITORS OF THE CYSTEINE PROTEASES 3CL PROTEASE, CATHEPSIN L, AND CRUZAIN
$233,247Thomas Meek · Texas A&M Agrilife Research · R21 · FY2022 · AI
Personalized Environment and Genes Study (PEGS)
$233,210Janet Hall · National Institute Of Environmental Health Sciences · ZIC · FY2021 · ES
Necroptosis in SARS-CoV-2 pathogenesis, evolution, and therapy
$233,000Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R21 · FY2023 · AI
Structural Basis for T Cell Recognition of SARS-CoV-2
$232,710Roy A Mariuzza · Univ Of Maryland, College Park · R21 · FY2023 · AI